“There is currently a $3.6 billion funding gap on malaria in Africa, according to the Roll Back Malaria Partnership, whose board concluded its 23rd meeting in Dakar, Senegal, on December 7,” Devex’s “Development Newswire” blog reports. Of the total, eight African countries — Nigeria, Central African Republic, Cote d’Ivoire, Democratic Republic of the Congo, Ethiopia, Mauritania, Niger, and Sierra Leone — need $2.4 billion to maintain their malaria prevention and treatment efforts over the next two years, “with Nigeria alone requiring nearly half that amount,” according to the blog (Ravelo, 12/10).
Access to Health Services
The Lancet examines Indonesia’s efforts to reduce maternal mortality, one of the Millennium Development Goals President Susilo Bambang Yudhoyono has identified as a national priority. Indonesia’s risk of maternal death is one in 150, compared with one in 4,000 in developed nations, and the government has set a goal of reducing mortality to 102 for every 100,000 live births by 2015, one-quarter of the rate in 1990, according to the journal. Gita Maya Koemara Sakti, recently appointed as director of maternal health, explained the Ministry of Health “has adopted a four-step plan that starts with bolstered family planning campaigns,” the Lancet writes. Other efforts include providing free maternal health care through the national social assistance system, improving the national midwifery program, and providing more funding to rural health clinics, the journal notes. The Lancet includes quotes from other government officials and non-governmental organization representatives regarding these efforts and the challenges faced (Webster, 12/8).
GlobalPost’s “Global Pulse” blog features an interview with freelance reporter and artist-in-residence at the University of Washington in Seattle Joanne Silberner, a former NPR correspondent, about her recent series for PRI’s “The World,” titled “Cancer’s New Battleground — The Developing World.” Produced in collaboration with the Pulitzer Center on Crisis Reporting, the series examines cancer prevention, control, and research efforts in Uganda, Haiti, India, and the U.S., according to the blog. Silberner said she was “astounded” to learn “there are more deaths from cancer (in the developing world) than if you added up the deaths from HIV, [tuberculosis], and malaria,” the blog notes. She also said she was “surprised” to learn about the stigma against cancer in the developing world, which “keeps people from coming in [to clinics]” and “keeps local governments from supporting treatment efforts.” Silberner also said coverage of global health issues is important to raise awareness and knowledge in the U.S. (Judem, 12/6).
New Public-Private Partnership Will Allow Brazil To Produce Patented ARV For National Treatment Program
For the first time, Brazil in 2013 will enter into a new type of public-private partnership that allows the nation to produce a generic version of the antiretroviral (ARV) drug atazanavir sulphate, which will be under patent through its producer Bristol-Myers Squibb until 2017, Inter Press Service reports. Under the “productive development partnership,” Farmanguinhos, “a technical-scientific unit of the Oswaldo Cruz Foundation (Fiocruz) and the Health Ministry’s largest pharmaceutical laboratory,” will make the drug, one of 20 ARVs the government distributes at a cost of about $425 million annually, according to the news service.
The “progress and momentum” behind stopping mother-to-child HIV transmission is “reason to celebrate,” Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Peter Twyman, CEO of Keep a Child Alive, write in The Hill’s “Congress Blog.” However, “as we set our sights on an AIDS-free generation, we must once again ensure that children currently living with HIV are not left behind,” they state. “Unfortunately, we’re not seeing the same level of progress with access to services for children who are already living with the virus,” they write and describe the challenges children and their families face in gaining access to HIV treatment and care, including stigma and fear and a lack of antiretroviral drug formulations for children.
In this PLoS “Speaking of Medicine” blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres’ (MSF) Access Campaign say that the WHO’s decision last week to “simply continue monitoring” the medical research and development (R&D) industry’s ability to address the needs of people living in developing countries “by creating a global R&D ‘observatory'” is “a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed.” They discuss how access to new tools, technologies, and treatments “can save lives” and some of the progress made in expanding R&D. Advocates’ “pressure will be critical for engaging governments and mobilizing the public leadership needed to support the research for cures that millions of neglected patients await,” they conclude (12/6).
UNFPA and mobile phone company Nokia announced this week that the “company will donate the equivalent of 3,000 clean delivery kits to the fund,” according to an UNFPA press release. “The kits, designed and distributed by UNFPA, help ensure safe delivery of babies in humanitarian settings,” and are being provided as a result of the fund’s social media campaign “Safe Birth. Even Here.,” the press release states, adding, “The campaign, which reports on and tracks safe deliveries in refugee camps and emergencies around the globe, is active on Twitter, Facebook and Pinterest, and aims to raise awareness about maternal health and the challenges faced by expectant mothers in crisis settings” (12/4).
In its continuing series titled “The State of AIDS,” GlobalPost examines the HIV/AIDS epidemic in Latin America and the Caribbean, where “[m]ajor gains have been made in the fight against the spread of HIV” over the past decade, particularly in stopping mother-to-child transmission (MTCT). However, some countries in the region have some of the highest HIV/AIDS prevalence rates outside of sub-Saharan Africa; “the disease continues to spread among certain at-risk populations,” such as men who have sex with men; and “nearly one-third of those infected in Latin America are still not getting treated,” the news service reports.
Chris Endean of the GAVI Alliance writes ahead of the GAVI Partners Forum in a CNN opinion piece about efforts to vaccinate members of the Maasai tribes in Tanzania’s Arusha National Park. Noting Maasai tribes are “constantly on the move searching for water and fresh pasture for their cattle,” he describes “severe logistical challenges” health workers face when trying to reach their patients and notes, “The need to get to hard-to-reach people like the Maasai and the rest of the estimated eight percent of Tanzania’s population that do not receive basic life-saving vaccines has taken on a new urgency with the country’s recent launch of a five-year development plan” called the “One Plan.” Endean notes the forum is taking place in the country’s capital, Dar es Salaam, and that during the event, “the health ministry will launch two new vaccines into the national immunization program — pneumococcal and rotavirus — tackling the primary causes of pneumonia and diarrhea — two of the leading killers of under-fives in Tanzania” (12/5).
PRI’s “The World” this week features a series examining the challenges of addressing cancer in the developing world. The series, produced in collaboration with the Pulitzer Center on Crisis Reporting, includes radio stories, multimedia features, an interactive map, and infographics, according to the main page. The radio stories examine cancer prevention, control, and research efforts in Uganda, Haiti, India, and the U.S. (12/3). In an interview with the series’ principal reporter, Joanne Silberner, Lancet editor Richard Horton said, “Cancer is certainly being under-recognized and neglected in low- and middle-income countries. … I think cancer is slowly becoming more recognized but there is a long way to go before it gets the attention it so urgently needs (12/3). On December 5, PRI will host a Facebook chat from 10am-4pm EST that will feature Silberner and cancer researchers and advocates (12/4).